Take overs, low float squeezes and cancer treatment

Details on what's moving the market this morning here 💃                                                                                                                                                                                                                                                                                                                                                                                                                 Good day, 360 – Here are our top investing ideas today – these setups look primed! And complimentary Rocket Trades 🚀training at 1pm EST → [join here](. ROOT- Up over 38% after receiving take over bid at $19.34 according to the WSJ, deal not finalized RNAZ- Up over 12% after publication of new data supporting use of TTX-MC138 for the treatment of metastatic breast cancer PIXY - Up over 130% in pre-market on no news (Complimentary Training 1pm EST Today) 📩143 Pages… And Counting!📩 Jeff Has 143 Pages of 🚀[Rocket Trade](🚀 Proof. Trades that Gained 100% or More! Trades not typical. Don’t expect to replicate. Losses happen. He’s Preparing to Add to This Soon… Making It 150+ Pages! Don’t Miss More Rocket Trades. [→ Limited Time Open Enrollment in Bullseye Unlimited]( Complimentary Training Today [JOIN ROOM HERE AT 1PM EST]( ROOT - Up over 38% after receiving take over bid at $19.34 according to the WSJ, deal not finalized Root Inc (ROOT) provides insurance products and services in the United States. Late yesterday, the [Wall Street Journal]( reported that the car insurance firm received a takeover bid at $19.34 but wasn’t able to complete negotiation of the deal. The stock closed up over 59% yesterday on the news at $9.62 and is gapping up another 38% this morning in pre-market, still well below the rumored takeover price. The $13 area has acted as support in the after-hours and pre-market and will be an important level to watch. Above it, targets to the upside are $15 and then the pre-market high at $15.70. Beyond that, targets are $17 and $18, Below $13, there is potential support at $12, $11 and a gap to fill at $9.62. RNAZ - Up over 12% after publication of new data supporting use of TTX-MC138 for the treatment of metastatic breast cancer TransCode Therapeutics (RNAZ) is a ribonucleic acid (RNA) oncology company, focusing on the development and commercialization of drugs and diagnostics for treating and identifying various cancers. The company [announced this morning]( the publication of new data supporting the use of TTX-MC138 for the treatment of metastatic breast cancer. ‘The study shows that inhibition of microRNA-10b, the therapeutic target of TTX-MC138, in breast cancer cells impaired the capacity of cancer stem cells to create new tumors and become metastatic. TransCode believes that these findings are important because cancer stem cells have long been known to play a critical role in cancer initiation, metastasis, recurrence, and resistance to therapy. Therefore, inhibiting the tumor-promoting capacity of these cells using TTX-MC138 could improve outcomes in patients with breast cancer that is recurrent and resistant to treatment.’ $3 has acted as support so far in the pre-market and will be an important level to watch. Above $3, targets to the upside are at $3.20, $3.40 and then the pre-market high of $3.46. Beyond that, $4 and then $5 come into play. Below $3, there is potential support at $2.80 and then a gap to fill at $2.71. PIXY - Up over 130% in pre-market on no news ShiftPixy (PIXY) provides staffing solutions in the United States. It offers employment administrative services, such as payroll processing, human resources consulting, and workers' compensation administration and coverage. There has been no news released regarding the company, however the stock is the top gainer for the day at over 130% in the pre-market. Perhaps someone knows something, or a short seller is stuck. According to Finviz, the stock has a float of only 1.37 million shares with over 11% short interest. The stock has already traded over 3 million shares this morning before market open. $3.26 is the pre-market high and will be the major level to watch for bulls. Above it, targets to the upside are $3.30, $3.53, $3.80, $4.20. $4.50 and then $4.70. Below $3.26, there is potential support at $3, $2.80, $2.50, $2.40, $2.20, $1.80 and then $1.60. The stock closed at $1.32 yesterday. [Economic Calendar]( To Your Success!   Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull  DISCLAIMER To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers. [RagingBull.com](, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. [tw]( Update your email preferences or unsubscribe [here]( © 360wallstreet 62 Calef Hwy. #233 Lee, NH 03861, United States [[beehiiv logo]Powered by beehiiv](